Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approach.
Saved in:
| Title: | Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approach. |
|---|---|
| Authors: | Lamy O; Department of Medicine, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. olivier.lamy@chuv.ch.; Interdisciplinary Center of Bone Diseases, Rheumatology Unit, Bone and Joint Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. olivier.lamy@chuv.ch.; Service de médecine interne, CHUV, Rue du Bugnon 46, Lausanne, 1011, Switzerland. olivier.lamy@chuv.ch., Everts-Graber J; OsteoRheuma Bern, Bahnhofplatz 1, Bern, Switzerland.; Department of Rheumatology and Immunology, University Hospital, Bern, Switzerland., Gonzalez Rodriguez E; Interdisciplinary Center of Bone Diseases, Rheumatology Unit, Bone and Joint Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. |
| Source: | Aging clinical and experimental research [Aging Clin Exp Res] 2025 Mar 08; Vol. 37 (1), pp. 70. Date of Electronic Publication: 2025 Mar 08. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 101132995 Publication Model: Electronic Cited Medium: Internet ISSN: 1720-8319 (Electronic) Linking ISSN: 15940667 NLM ISO Abbreviation: Aging Clin Exp Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
